The MultiPepT1De Study—Examining the Safety of Peptide Immunotherapy Using Multiple Islet Antigens in Recent-Onset Type 1 DiabetesYF Liu, Mark Peakman, Sefina Arif et al.|Diabetes|2018Cited by 3